On March 25, the Shanghai Industrial Technology Innovation Promotion Association, the City Association for Science and Technology and the Baoshan District Government released the "2023 Shanghai Hardcore Technology Enterprises TOP100 List". The selected companies from the list covers enterprise technology centers, listed companies, top 100 emerging industries, top 100 private manufacturing companies, and companies undertaking major municipal-level scientific and technological projects.
Shanghai Medicilon Inc. stood out from more than 1,500 outstanding companies and was successfully selected into the list of "2023 Shanghai Hardcore Technology Enterprises TOP 100 List".
The recognition of Shanghai's hard-core technology enterprise is the official recognition of Medicilon's comprehensive R&D technology innovation, technical service platform, and drug R&D empowerment. It is also an affirmation of Medicilon's achievements in the field of pharmaceutical research and development, as well as its influence and driving force on the industry.